Chromatin engineering offers an opportunity to advance epigenetic cancer therapy
Crossref DOI link: https://doi.org/10.1038/s41594-019-0299-6
Published Online: 2019-10-03
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baskin, Natecia L.
Haynes, Karmella A. http://orcid.org/0000-0002-5975-577X
Text and Data Mining valid from 2019-10-01
Version of Record valid from 2019-10-01
Article History
First Online: 3 October 2019
Competing interests
: The authors declare no competing interests.